logo
logo
logo

logo

HOME/FACULTY& STAFF/ PROFILE

Pharmaceutical Analysis Department >
Dr. Amit Asthana >
Dr. S. Gananadhamu >
Dr. Rajesh Sonti >
Dr. Amol G. Dikundwar >

Faculty Profile : DR. S. Gananadhamu

Name: Dr. S. Gananadhamu


Assistant Professor
gana.niperhyd@gov.in
+91 40 23074750 Extn- 2013
+91-040-23074750 (Ext. No: 2013)


ADDRESS, ROOM NO


Department of Pharmaceutical Analysis
Room no: 48
NIPER Hyderabad
Balanagar, Hyderabad-500037, TS, INDIA



QUALIFICATION: (REVERSE CHRONOLOGICAL ORDER)

Ph.D (Andhra University),
M.Pharm (Andhra University) and
B.Pharm (Acharya Nagarjuna University)



EXPERIENCE

  • Currently working as assistant professor at NIPER, Hyderabad since 2009.
  • 3 years and 9 months as a senior lecturer at at K.V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada (December 2005 to August 2009).
  • 2 years and 3 months as a scientist-II at Torrent Research Centre, Village-Bhatt, Gandhinagar, Gujarat (September 2003 to November 2005).



COURSES HANDLING(PHD/M.PHARM)

M.S (Pharm):
Topics in Pharmaceutical Analysis (PA-510)
Quality Control and Quality Assurance (PA-610)
Pharmacopeial Methods of Analysis (PA-640)
Ph.D:
Method Development and Trouble Shooting of GC and HPLC (PA-720)
Analytical Chemometrics (PA-750)



PHD STUDENTS/MASTERS STUDENTS

Masters: Submitted -9 [Advisor] + 28 [Joint Advisor]
Ongoing - 1 [Advisor] + 4 [Joint Advisor]
Ph.D: Submitted -1 [Advisor] + 1 [Joint Advisor]
Ongoing - 3 [Advisor]



AWARDS / HONOURS
  • APP (Association of Pharmaceutical Professionals) young talent award 2016 (2016)

  • Associate fellow of Telangana Academy of Sciences (2016)


RESEARCH AREAS/INTEREST
  • Study of drug degradation chemistry and drug stability testing
  • Impurity profiling of drugs
  • Bioanalytical method development and metabolite profiling
  • Development of new analytical methods for detecting the counterfeit of drugs
  • Analytical method development for release testing of active pharmaceutical ingredients and pharmaceutical formulations
  • Preformulation studies
  • Standardization of herbal drugs


PUBLICATIONS / BOOK CHAPTERS

1) S. Gananadhamu.; Debasish Swain.; Gayatri Sahu.; Shweta Bhagat.; P.V. Bharatam. Ultra HPLC Method for Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone: Identification and in silico Toxicity Prediction of Degradation Products, Journal of Analytical Chemistry, 2018, 73 (6), 560-569.
2) M. Thummar.; Debasish Swain.; S. Gananadhamu. Separation and Characterization of New Forced Degradation Products of Macitentan: A Dual Endothelin Receptor Antagonist, Chromatographia, 2018, 81, 525– 531.
3) M. Thummar.; P. N. Patel.; S. Gananadhamu.; R. Srinivas. Stability indicating assay method for acotiamide: separation, identification and characterization of its hydroxylated and hydrolytic degradation products along with a process related impurity by UHPLC‐ESI‐QTOF‐MS/MS, Rapid communications in mass spectrometry, 2017, 31, 1813-1824.
4) P. N. Patel.; P. D. Kalariya.; M. Thummar.; S. Gananadhamu.; R. Srinivas. In vivo metabolite identification of acotiamide in rats using ultra‐performance liquid chromatography‐quadrupole/time‐of‐flight mass spectrometry, Biomedical Chromatography, 2017 (In-press)
5) Pradipbhai D. Kalariya.; Deepak, N.; Srinivas, R.; Gananadhamu, S. Application of experimental design and response surface technique for selecting the optimum RP-HPLC conditions for the determination of moxifloxacin HCl and ketorolac tromethamine in eye drops. Journal of Saudi Chemical Society, 2017, 71, S373-S382.
6) Mohit Thummar.; Prinesh N. Patel.; Arun L. Petkar.; Debasish Swain.; R. Srinivas.; Gananadhamu Samanthula. Identification of degradation products of saquinavir mesylate by ultra‐high‐performance liquid chromatography/electrospray ionization quadrupole time‐of‐flight tandem mass spectrometry and its application to quality control, Rapid communications in mass spectrometry, 2017, 31, 771-781.
7) Debasish Swain.; Gananadhamu Samanthula. Study on the forced degradation behaviour of ledipasvir: Identification of major degradation products using LC–QTOF–MS/MS and NMR, Journal of Pharmaceutical and Biomedical Analysis, 2017,138, 29-42.
8) Vishnuvardhan C, Saibaba B, Allakonda L, Swain D, Gananadhamu S, Srinivas R, Satheeshkumar N; LC-ESI-MS/MS evaluation of forced degradation behaviour of silodosin: In vitro anti cancer activity evaluation of silodosin and major degradation products. J Pharm Biomed Anal. , 2017, 134, 1-10.
9) Chiguru Vishnuvardhan, Debasish Swain, Roshan Borkar, S. Gananadhamu, R. Srinivas, N. Satheeshkumar.; Study of forced degradation behaviour of brinzolamide using LC-ESI- Q-TOF and in silico toxicity prediction. Chromatographia, 2016, 79, 1293.
10) Prinesh N. Patel.; Pradipbhai D. Kalariya.; Swamy C.V.; Gananadhamu S.; Srinivas R. Quantitation of acotiamide in rat plasma by UHPLC-Q-TOF-MS: method development, validation and application to pharmacokinetics. Biomed Chromatogr. 2016, 30, 363-368.
11) Debasish Swain.; Prinesh N Patel.; Gangam Nagaraj.; Kona S Srinivas.; Mahesh Sharma.; Prabha Garg.; Gananadhamu Samanthula. Liquid Chromatographic Method Development for Forced Degradation Products of Dabigatran Etexilate: Characterisation and In Silico Toxicity Evaluation. Chromatographia. 2016, 79, 169-178.
12) Debasish Swain.; Gananadhamu Samanthula.; Shweta Bhagat.; P.V. Bharatam.; Venkatakrishna Akula.; Barij N. Sinha. Characterization of forced degradation products and in silico toxicity prediction of Sofosbuvir: A novel HCV NS5B polymerase inhibitor. J. Pharm. Biomed. Anal. 2016, 120, 352-363.
13) Prinesh N. Patel.; Vijaya Saradhi Karakam.; Gananadhamu S.; Srinivas R. Quality-by-design-based ultra high performance liquid chromatography related substances method development by establishing the proficient design space for sumatriptan and naproxen combination. J. Sep. Sci. 2015, 38(19), 3354-62.
14) Swain D.; Sahu G.; Samanthula G. Rapid LC-MS compatible stability indicating assay method for azilsartan medoxomil potassium. J. Anal. Bioanal. Tech. 2015, 6, 254.
15) Prinesh N. Patel.; Pradipbhai D. Kalariya.; Gananadhamu S.; Srinivas R. Forced degradation of fingolimod: Effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF–MS/MS and 1H NMR. J. Pharm. Biomed. Anal. 2015, 115, 388-394.
16) Debasish Swain.; Prinesh N. Patel.; Ilayaraja Palaniappan.; Gayatri Sahu.; Gananadhamu Samanthula. Liquid Chromatography-Tandem Mass Spectrometry Study of Forced Degradation of Azilsartan Medoxomil Potassium. Rapid Commun. Mass spectrom, 2015, 29, 1437–1447.
17) Prinesh N. Patel.; Pradipbhai D. Kalariya.; Mahesh Sharma.; Prabha Garg.; M. V. N Kumar Talluri.; Gananadhamu Samanthula.; Srinivas Ragampeta. Characterization of forced degradation products of pazopanib hydrochloride by UHPLC-Q-TOF/MS and in silico toxicity prediction, J. Mass Spectrom. 2015, 50, 918–928.
18) Prinesh N. Patel.; D. Rajesh Kumar.; S. Gananadhamu.; R. Srinivas. Characterization of the stress degradation products of tolvaptan by UPLCQ-TOF-MS/MS, RSC Adv., 2015, 5, 21142-21152.
19) Prinesh N. Patel.; Roshan M. Borkar.; Pradipbhai D. Kalariya.; Rahul P. Gangwal.; Abhay T. Sangamwar.; Gananadhamu Samanthula.; Srinivas Ragampeta. Characterization of degradation products of Ivabradine by LCHR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis, J. Mass Spectrom. 2015, 50, 344–353.
20) Samanthula, G.; Shrigod, V. V.; Patel, P. N. Validated Stability-Indicating Assay Method for Simultaneous Determination of Aceclofenac and Thiocolchicoside using RP-HPLC, Drug Research. 2014, 64, 429-435.
21) Pradipbhai D. Kalariya, B. Raju, Roshan M. Borkar, Deepak Namdev, S. Gananadhamu, Prajwal P. Nandekar, Abhay T. Sangamwar, R. Srinivas. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction, J. Mass Spectrom. 2014, 49, 380–391.
22) Deepak, N.; Roshan, M. B.; Raju, B.; Pradipbhai, D. K.; Vinodkumar, T. R.; Gananadhamu, S.; Srinivas, R. Identification of forced degradation products of Tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 2014, 88, 245-255. 23) Prinesh N. Patel.; Gananadhamu Samanthula.; Veeraraghavan Sridhar.; Rambabu Arla.; Kanthi Kiran V. S. Varanasi.; Swaroop Kumar V.V.S. Validated LC-MS/MS method for simultaneous determination of Dasatinib and Sitagliptin in rat plasma and its application to pharmacokinetic study, Anal. Methods. 2014, 6, 433-439.
24) Prinesh, N.P.; Gananadhamu, S.; Vishalkumar, S.; Sudipkumar, C. M.; Jainishkumar, R. C. RP-HPLC method for determination of several NSAIDs and their combination drugs. Chromatography Research International, 2013, 2013, 13.
25) Gananadhamu, S.; Krishnaveni, Y.; Shantikumar, S.; Sreekanth, G.; Surendranath, K. V. Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Doxophylline and Terbutalinesulphate in Pharmaceutical Formulations. Sci. Pharm. 2013, 81, 969–982.
26) Gananadhamu, S.; Laxmikanth, V.; Shantikumar, S; Sridhar, V; Geetha, C; Sandhya, C. Rapid LC-ESI-MS-MS Method for the Simultaneous Determination of Sitagliptin and Pioglitazone in Rat Plasma and Its Application to Pharmacokinetic Study. American Journal of Analytical Chemistry. 2012, 3, 849-858.
27) Ramakrishna Y.; Mohd. M.; Ramakrishna B.; Gananadhamu, S. Development and Validation of a New RP-HPLC Method for the Estimation of Valsartan and Hydrochlorothiazide in Tablets, IJPI’s Journal of Analytical Chemistry. 2012, 2(8), 13-19.
28) Santhi, N.; Deepthi, Ch.; Rajendran, S.S.; Gananadhamu, S.; Devala Rao, G.; Sai, L. Spectrophotometric estimation of Ziprasidone in bulk and in Pharmaceutical formulations. Asian Journal of Pharmaceutical Analysis, 2011, 1(1), 08-09.
29) Ravisankar, P.; Deva Dasu, Ch.; Srinivasa Babu, P.; Devala Rao, G.; Gananadhamu, S. Development and Validation of New RP-HPLC Method for the Estimation of Prulifloxacin in Pharmaceutical Dosage Forms. International Journal of Chemical Sciences, 2010, 8(1), 433-444.
30) Sastry, B.S.; Gananadhamu, S.; Prasad, S.V.S.G.B.; Venu Gopala Raju, K. New spectrophotometric methods for the estimation of Lenalidomide in pharmaceutical formulations. Journal of Pharma Tech Research, 2009, 1(3), 416-419.
31) Gananadhamu, S.; Sastry, B. S.; Devala Rao, G. RP-HPLC determination of aripiprazole in pharmaceutical formulations. Asian journal of chemistry, 2009, 21(9), 6643-6646. 32) Sastry, B. S.; Gananadhamu, S.; Devala Rao, G. Estimation of Aripiprazole in pharmaceutical formulations by spectrophotometry. Acta Ciencia Indica, 2008, 34C (4), 631.
33) Gananadhamu, S.; Sastry, B. S.; Devala Rao, G. Development of RPHPLC Method for estimation of Drotaverine Hydrochloride in pharmaceutical formulations. International Journal of Chemical Sciences, 2008, 6(4), 2055-2061.
34) Sastry, B.S.; Gananadhamu, S.; Devadasu, Ch.; Balaji, K. New RP-HPLC Method for estimation of Donepezil hydrochloride in pharmaceutical formulations. International Journal of Chemical Sciences, 2008, 6(4), 1976- 1983.
35) Krishna, P.; Devala Rao, G.; Gananadhamu, S. Development of HPLC method for the determination of Zaleplon in pharmaceutical formulations. Acta Ciencia Indica, 2008, 34 C, 4, 623.
36) Elayaraja, A.; Rahaman, S. A.; Gananadhamu, S.; Devala Rao, G. Antibacterial Activity of Various Crude Extracts of Justicia tranquebariensis. Journal of pure and applied microbiology, 2008, 2(1) Page No. 231-233.
37) Sastry, B. S.; Gananadhamu, S.; Devala Rao, G. Visible spectrophotometric methods for estimation of Aripiprazole in pharmaceutical formulations. International Journal of Chemical Sciences, 2007, 5(5), 2197-2202.
38) Gananadhamu, S.; Sastry, B. S.; Devala Rao, G. Extractive spectrophotometric determination of Donepezil hydrochloride. International Journal of Chemical Sciences, 2007, 5(3), 1150-1154.
39) Sastry, B. S.; Gananadhamu, S.; Devala Rao, G. New spectrophotometric methods for estimation of Donepezil hydrochloride in pharmaceutical formulations. Acta Ciencia Indica, 2007, 33C (4), 411.
40) Sastry, B. S.; Gananadhamu, S.; Devala Rao, G. 2,4-DNPH: A chromogenic reagent for estimation of Donepezil hydrochloride in pharmaceutical formulations. Journal of Pharmaceutical research, 2007, 6(3), 176-177.
41) Gananadhamu, S.; Sastry, B. S.; Devala Rao, G. Extractive spectrophotometric determination of Drotaverine hydrochloride in pharmaceutical formulations. Acta Ciencia Indica, 2006, 32C (3), 331.



PATENTS
  • -


INVITED TALKS

1) “UHPLC: A Green chromatographic technique” at a conference on “New horizons of green synthetic and analytical techniques” organized by K.V.S.R. Siddhartha College of Pharmaceutical Sciences, Vijayawada on 23rd September 2017.
2) “Practical conduct of impurity profiling” at a workshop on “Hands-on training, troubleshooting, method development and validation techniques in HPLC and UPLC” conducted by Spectrum pharma research solutions, Hyderabad on 3rd September 2017.
3) “Identification of drug degradation products by using high resolution mass spectrometry” at “PHARMA NIPUNA – 2017” conference by Venkateshwara Institute of Pharmaceutical Sciences, Charlapally, Nalgonda on 1st April 2017.
4) “Impurity profiling of pharmaceuticals” at 2nd Indo-Korean conference on “Herbals and Pharmaceuticals: Pivotal Issues and Concerns” conducted at Gokula Krishna College of Pharmacy, Sullurpeta on 30th March 2016.
5) “GC-MS method development” at Quality Improvement Programme for Faculty conducted by University College of Pharmaceutical Sciences, Kakatiya University, Warangal on 1st November 2014.
6) “Role of Modern Instrumentation Techniques In Current Concepts of Pharmaceutical Sciences” at the UGC sponsored National Workshop was organized at ANU College of Pharmaceutical Sciences, Guntur on 14th March 2014.

ADDITIONAL RESPONSIBILITIES

Additional controller of examinations



ANY OTHER INFORMATION